DSM-Firmenich AG (AMS:DSFIR)
Netherlands · Delayed Price · Currency is EUR | Market Cap | 19.29B |
| Revenue (ttm) | 13.01B |
| Net Income (ttm) | 718.00M |
| Shares Out | 254.26M |
| EPS (ttm) | 2.72 |
| PE Ratio | 27.93 |
| Forward PE | 18.89 |
| Dividend | 2.50 (3.29%) |
| Ex-Dividend Date | May 8, 2025 |
| Volume | 423,894 |
| Average Volume | 603,113 |
| Open | 75.36 |
| Previous Close | 75.54 |
| Day's Range | 75.20 - 76.00 |
| 52-Week Range | 70.94 - 115.70 |
| Beta | 0.98 |
| RSI | 53.58 |
| Earnings Date | Feb 12, 2026 |
About DSM-Firmenich AG
DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through four segments: Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and s... [Read more]
Financial Performance
In 2024, DSM-Firmenich AG's revenue was 12.80 billion, an increase of 20.44% compared to the previous year's 10.63 billion. Earnings were 250.00 million, a decrease of -88.27%.
Financial StatementsNews
How high-cost Switzerland stayed a manufacturing powerhouse in the offshore era
What is the lesson of Swiss Fortune 500 companies—such as DSM-Firmenich—for the rest of Europe, and the world?
DSM-Firmenich (DSFIY) Reopens Auction for Animal Nutrition Unit
DSM-Firmenich (DSFIY) Reopens Auction for Animal Nutrition Unit
Apollo asked to rejoin DSM-Firmenich’s auction as CVC bid stalls: report
Apollo Global Management (NYSE:APO) has been asked to rejoin in the auction of DSM-Firmenich's (KDSKF) animal nutrition and health unit. Read more here.
DSM-Firmenich AG 2025 Q2 - Results - Earnings Call Presentation
DSM-Firmenich AG (DSFIY) Q2 2025 Earnings Call Transcript
DSM-Firmenich AG (KDSKF) Q1 2025 Earnings Call Transcript
DSM-Firmenich is a smarter, faster working engine post merger, says CEO
Dimitri De Vreeze, CEO of Dsm-Firmenich, talks about the company's merger and share buyback program off the back of its full-year earning results.
DSM-firmenich Launches 1 Billion-EuroShare BuybackAfterEarnings Rise
DSM-Firmenich AG (KDSKF) Q3 2024 Earnings Call Transcript
Reducing Cattle’s Footprint
Cow flatulence is a significant contributor to the greenhouse gas in our atmosphere. Dutch company DSM-Firmenich’s Bovaer addresses that issue at source: The feed additive slows down the last step of ...
DSM-Firmenich: Making Progress, Still Far From Delivering On Its Full Potential
Pavel Bittner birla por una llanta un sprint de foto-finish a Van Aert
El joven checo de 21 aos, del Team DSM-Firmenich, logr su tercera victoria de etapa como profesional
FutureFuel names Koninklijke's Polet as new CEO
FutureFuel names Koninklijke's Polet as new CEO
DSM-Firmenich AG (KDSKF) Q2 2024 Earnings Call Transcript
DSM-Firmenich AG (OTC:KDSKF) Q2 2024 Earnings Conference Call July 30, 2024 3:00 AM ET Company Participants Dave Huizing - Head of Investor Relations Dimitri de Vreeze - Chief Executive Officer Ralf S...
DSM-Firmenich AG (KDSKF) Q1 2024 Earnings Call Transcript
DSM-Firmenich AG (OTC:KDSKF) Q1 2024 Earnings Conference Call May 2, 2024 3:00 AM ET Company Participants Dave Huizing - Head of Investor Relations Ralf Schmeitz - Chief Financial Officer Conference C...
Royal DSM: Quality At A Price
Royal DSM has proven its resilience through the near-term macro challenges. Its upcoming merger with Firmenich also appears promising and could deliver upside going forward.
Koninklijke DSM N.V. (RDSMY) CEO Geraldine Matchett on Q2 2022 Results - Earnings Call Transcript
Koninklijke DSM N.V. (OTCQX:RDSMY) Q2 2022 Results Conference Call August 2, 2022 8:00 AM ET Company Participants Dave Huizing - Vice President of Investor Relations Geraldine Matchett - Chief Executi...
Health and biotech firm says it has enjoyed resilient demand as health kick is here to stay
Dimitri de Vreeze, co-CEO of DSM, discusses his company's earnings and explains why demand has remained strong.
'A merger of equals': Firmenich CEO Ghostine on DSM deal
Firmenich CEO Gilbert Ghostine describes the company's deal with sector peer DSM as a "merger of equals."
5 Great Green Stocks Making a Direct Impact
It's the end of business as usual. To save the planet, consumers, companies and governments all over the world are stepping up their sustainability game, or at least pledging to do so.
Koninklijke DSM N.V. (RDSMY) on Q4 and FY 2021 Results - Earnings Call Transcript
Koninklijke DSM N.V. (RDSMY) on Q4 and FY 2021 Results - Earnings Call Transcript
DSM co-CEO: Inflationary pressures offset by 4% price increase in some business areas
Geraldine Matchett, co-CEO of DSM and member of CNBC's ESG Council, provides a deep dive into the company's fourth-quarter results and shares how DSM are tackling rising inflation.
Very Confident to Increase Our Outlook: DSM Co-CEO
Aug.04 -- DSM Co-CEO Dimitri de Vreeze discusses the company's earnings, emissions and sustainable foods. He speaks with Bloomberg's Anna Edwards and Mark Cudmore on "Bloomberg: European Market Open".
Koninklijke DSM NV (RDSMY) CEO Dimitri de Vreeze on Q4 2020 Results - Earnings Call Transcript
Koninklijke DSM NV (RDSMY) CEO Dimitri de Vreeze on Q4 2020 Results - Earnings Call Transcript